These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
304 related items for PubMed ID: 25838092
1. Safety and efficacy of a new regimen of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: a prospective, randomized, open-label study. Murakami D, Sawatsubashi M, Kikkawa S, Ejima M, Saito A, Kato A, Komune S. Allergol Int; 2015 Apr; 64(2):161-8. PubMed ID: 25838092 [Abstract] [Full Text] [Related]
2. Phase I/II study of oral immunotherapy with Cry j1-galactomannan conjugate for Japanese cedar pollinosis. Murakami D, Kubo K, Sawatsubashi M, Kikkawa S, Ejima M, Saito A, Kato A, Komune S. Auris Nasus Larynx; 2014 Aug; 41(4):350-8. PubMed ID: 24698163 [Abstract] [Full Text] [Related]
3. Effect of short-term oral immunotherapy with Cry j1-galactomannan conjugate on quality of life in Japanese cedar pollinosis patients: A prospective, randomized, open-label study. Murakami D, Sawatsubashi M, Kikkawa S, Ejima M, Saito A, Kato A, Komune S. Auris Nasus Larynx; 2016 Feb; 43(1):50-5. PubMed ID: 26197940 [Abstract] [Full Text] [Related]
4. Safety and efficacy of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: a randomized controlled trial. Murakami D, Sawatsubashi M, Omori H, Saito A, Kato A, Komune S, Nakagawa T. Sci Rep; 2017 Apr 11; 7():46142. PubMed ID: 28397833 [Abstract] [Full Text] [Related]
5. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis. Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Yamamoto H, Kunii N, Sakurai D, Fujimura T, Nakazawa K, Yasueda H. Int Arch Allergy Immunol; 2008 Apr 11; 146(1):76-84. PubMed ID: 18087165 [Abstract] [Full Text] [Related]
7. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract]. Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Kunii N, Yamamoto H, Sakurai D, Hanazawa T. Arerugi; 2008 May 11; 57(5):558-61. PubMed ID: 18520178 [Abstract] [Full Text] [Related]
8. Recombinant Fusion Allergens, Cry j 1 and Cry j 2 from Japanese Cedar Pollen, Conjugated with Polyethylene Glycol Potentiate the Attenuation of Cry j 1-Specific IgE Production in Cry j 1-Sensitized Mice and Japanese Cedar Pollen Allergen-Sensitized Monkeys. Fujimura T, Fujinami K, Ishikawa R, Tateno M, Tahara Y, Okumura Y, Ohta H, Miyazaki H, Taniguchi M. Int Arch Allergy Immunol; 2015 May 11; 168(1):32-43. PubMed ID: 26524293 [Abstract] [Full Text] [Related]
9. Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar-specific ASIT. Osada T, Tanaka Y, Yamada A, Sasaki E, Utsugi T. Allergol Int; 2018 Oct 11; 67(4):467-474. PubMed ID: 29525489 [Abstract] [Full Text] [Related]
11. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis. Okamoto Y, Okubo K, Yonekura S, Hashiguchi K, Goto M, Otsuka T, Murata T, Nakao Y, Kanazawa C, Nagakura H, Okawa T, Nakano K, Hisamitsu M, Kaneko S, Konno A. Int Arch Allergy Immunol; 2015 Oct 11; 166(3):177-88. PubMed ID: 25895909 [Abstract] [Full Text] [Related]
13. Immunological effects of sublingual immunotherapy with Japanese cedar pollen extract in patients with combined Japanese cedar and Japanese cypress pollinosis. Kikuoka H, Kouzaki H, Matsumoto K, Arai H, Yamamoto S, Tojima I, Shimizu S, Miyashita H, Ogawa Y, Osada T, Okano M, Yuta A, Shimizu T. Clin Immunol; 2020 Jan 11; 210():108310. PubMed ID: 31743749 [Abstract] [Full Text] [Related]
14. Immunological parameters associated with the development of allergic rhinitis: a preliminary prospective study. Uekusa Y, Inamine A, Yonekura S, Horiguchi S, Fujimura T, Sakurai D, Yamamoto H, Suzuki H, Hanazawa T, Okamoto Y. Am J Rhinol Allergy; 2012 Jan 11; 26(2):92-6. PubMed ID: 22487284 [Abstract] [Full Text] [Related]
15. The Relationship of Pollen Dispersal with Allergy Symptoms and Immunotherapy: Allergen Immunotherapy Improves Symptoms in the Late Period of Japanese Cedar Pollen Dispersal. Sakurai T, Yonekura S, Iinuma T, Sakurai D, Morimoto Y, Kaneko S, Okamoto Y. Int Arch Allergy Immunol; 2018 Jan 11; 177(3):245-254. PubMed ID: 30021201 [Abstract] [Full Text] [Related]
16. Effect of antihistamine eye drops on the conjunctival provocation test with Japanese cedar pollen allergen. Dake Y, Enomoto T, Cheng L, Enomoto K, Shibano A, Ikeda H, Yoda S, Yajin S, Sakota T, Yamanishi E. Allergol Int; 2006 Dec 11; 55(4):373-8. PubMed ID: 17130679 [Abstract] [Full Text] [Related]
17. Relationship between airborne Cry j 1 and the onset time of the symptoms of Japanese cedar pollinosis patients. Takahashi Y, Aoyama M, Yoshitake M, Abe E, Ohta N, Sakaguchi M. Allergol Int; 2007 Sep 11; 56(3):277-83. PubMed ID: 17582210 [Abstract] [Full Text] [Related]
18. Clinical effects of immunotherapy on Japanese cedar pollinosis in the season of cedar and cypress pollination. Ito Y, Takahashi Y, Fujita T, Fukuyama S. Auris Nasus Larynx; 1997 Apr 11; 24(2):163-70. PubMed ID: 9134139 [Abstract] [Full Text] [Related]
19. Analysis of helper T cell responses to Cry j 1-derived peptides in patients with nasal allergy: candidate for peptide-based immunotherapy of Japanese cedar pollinosis. Masuyama K, Chikamatsu K, Ikagawa S, Matsuoka T, Takahashi G, Yamamoto T, Endo S. Allergol Int; 2009 Mar 11; 58(1):63-70. PubMed ID: 19050376 [Abstract] [Full Text] [Related]